ArticleFrontiers in immunology2020

A Peptide-Based PD1 Antagonist Enhances T-Cell Priming and Efficacy of a Prophylactic Malaria Vaccine and Promotes Survival in a Lethal Malaria Model.

Timothy W Phares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.